Skip to Main Content
Try STAT+ TODAY
Trending:
STAT+
Health
Biotech
Pharma
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Horizon Therapeutics in acquisition talks with Amgen, Janssen, and Sanofi

  • Allison DeAngelis

By Allison DeAngelis Nov. 29, 2022

Reprints
Nasdaq
Mario Tama/Getty Images

Amgen, Janssen, and Sanofi are in talks to acquire Horizon Therapeutics, the Irish drugmaker confirmed Tuesday.

Horizon confirmed the discussions following a report in the Wall Street Journal, adding that the conversations were “highly preliminary.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Allison DeAngelis

Allison DeAngelis

Biotech Startups and Venture Capital Reporter

Allison DeAngelis is a biotech reporter at STAT, covering biopharma startups and venture capital.

Tags

Create a display name to comment

This name will appear with your comment

I was laid off from a public health job.…
I was laid off from a public health job. Trust me, tech layoffs are different
Medicare Advantage insurers will score $2 billion gift thanks…
Medicare Advantage insurers will score $2 billion gift thanks to limited audits
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Turkish court hands Novartis and Roche a rare win…
Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye…
Up and down the ladder: The latest comings and…
Up and down the ladder: The latest comings and goings
Pharmalittle: ALS Association and its chapters battle over money…
Pharmalittle: ALS Association and its chapters battle over money and priorities; eye drops recalled over links…

Recommended Stories